NEOPLASMS, RECTAL
Clinical trials for NEOPLASMS, RECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, RECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, RECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One drug could cure rectal cancer, spare patients from surgery
⭐️ CURE ⭐️ OngoingThis study is testing whether a single immunotherapy drug, dostarlimab, can effectively treat a specific type of rectal cancer without needing chemotherapy, radiation, or surgery. It involves 154 adults with untreated, locally advanced rectal cancer that has a specific genetic ma…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ CURE ⭐️
Last updated Mar 24, 2026 12:02 UTC
-
Immunotherapy trial aims to spare rectal cancer patients from surgery
Disease control OngoingThis study is testing whether a drug called dostarlimab can control a specific type of rectal cancer without needing surgery or radiation first. It is for Chinese patients with untreated, locally advanced cancer that has certain genetic markers. The main goal is to see if the dru…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC